Results 21 to 30 of about 23,635 (276)
Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases [PDF]
, 2018 Introduction: Rituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in studies of pemphigus vulgaris, but data of pemphigoid diseases are limited ...
Euverman, H. Ilona +4 more
core +14 more sources
Acta Dermato-Venereologica, 2020 Evidence about the association of bullous pemphigoid and the risk of cancer is conflicting. Patients diagnosed with bullous pemphigoid (n = 5,739) between 2005 and 2016 were matched with a control cohort from the general population (n = 17,168) to ...
Zeyad Albadri +4 more
doaj +1 more source
Annular bullous pemphigoid: A case report and review of literature
SAGE Open Medical Case Reports, 2022 Bullous pemphigoid is an autoimmune blistering disease that primarily affects the geriatric population. It often presents as urticarial erythematous plaques, which evolve into subepidermal blisters accompanied by pruritus.
Steffie Arès +4 more
doaj +1 more source
IgE autoantibodies and their association with the disease activity and phenotype in Bullous Pemphigoid: a systematic review [PDF]
, 2017 Bullous Pemphigoid (BP) is the most common autoimmune skin disease of blistering character. The underlying pathophysiological mechanism involves an immune attack, usually by IgG class autoantibodies, on the autoantigen BP 180/BPAg2, which is a type XVII ...
Fairclough, Lucy C. +3 more
core +2 more sources
Pemphigoid diseases in infancy and childhood. A review of the literature
Przegląd Dermatologiczny, 2023 Bullous pemphigoid is an autoimmune blistering disease that very rarely affects children. Clinical differences in locations of skin lesions led to the distinction of infantile versus childhood pemphigoid. Mucous membranes can be affected.
Magdalena Jałowska +2 more
doaj +1 more source
SAGE Open Medical Case Reports, 2022 Bullous pemphigoid is an acquired autoimmune blistering dermatosis that is commonly associated with high morbidity and mortality. New-onset bullous pemphigoid following vaccinations has rarely been reported in the literature.
Vincent Wan +3 more
doaj +1 more source
Paraneoplastic bullous pemphigoid – A sign of clear cell renal carcinoma
Urology Case Reports, 2020 Paraneoplastic bullous pemphigoid is a rare paraneoplastic syndrome. Rash is pruritic, with erythematous eruption of large subepidermal bullae over skin and often mucosal surfaces.
Stuart R. Jackson +5 more
doaj +1 more source
Bullous pemphigoid in infants: characteristics, diagnosis and treatment [PDF]
, 2014 BACKGROUND: Bullous pemphigoid (BP) in infants is a rare but increasingly reported autoimmune blistering skin disease. Autoantibody reactivity is usually poorly characterized. Current guidelines do not address specific aspects of the infantile form of BP.
Agnes Schwieger-Briel +8 more
core +2 more sources
Bullous Pemphigoid-like Skin Eruption during Treatment with Rivaroxaban: A Clinical Case Study [PDF]
, 2018 Little has been documented about hypersensitivity reactions caused by treatment with rivaroxaban. This paper reports a bullous pemphigoid-like skin eruption that occurred in a 76-year-old female patient during rivaroxaban treatment.
Almeida Ribeiro, Jose +4 more
core +2 more sources
JEADV Clinical Practice, 2023 Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed.
Shin Iinuma +2 more
doaj +1 more source